INT9688

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.73
First Reported 1992
Last Reported 2005
Negated 0
Speculated 0
Reported most in Abstract
Documents 3
Total Number 4
Disease Relevance 0.96
Pain Relevance 0.57

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

transport (Tap1) mitochondrion (Tap1) endoplasmic reticulum (Tap1)
ATPase activity (Tap1) plasma membrane (Tap1) transmembrane transport (Tap1)
Anatomy Link Frequency
D-17 1
Tap1 (Mus musculus)
Pain Link Frequency Relevance Heat
fluoxetine 5 97.64 Very High Very High Very High
agonist 2 97.52 Very High Very High Very High
depression 1 91.32 High High
palliative 1 25.00 Low Low
Potency 4 5.00 Very Low Very Low Very Low
anesthesia 2 5.00 Very Low Very Low Very Low
adenocard 2 5.00 Very Low Very Low Very Low
isoflurane 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Infection 38 98.16 Very High Very High Very High
Prostate Cancer 3 96.60 Very High Very High Very High
Depression 1 91.32 High High
Disease 4 42.72 Quite Low
Metastasis 1 34.08 Quite Low
Viral Infection 10 27.04 Quite Low
Adverse Drug Reaction 1 25.00 Low Low
Pox Virus Infection 30 9.76 Low Low
Sprains And Strains 16 5.00 Very Low Very Low Very Low
Vesicular Stomatitis 8 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Calculations based on the threshold cycle number indicated that the abundance of human TAP1 mRNA was equal to mouse TAP1 mRNA 4 and 8 h after infection, but decreased to 2% of endogenous mouse TAP1 mRNA by 24 h after infection.
Localization (abundance) of TAP1 mRNA associated with infection
1) Confidence 0.73 Published 2005 Journal PLoS Pathogens Section Body Doc Link PMC1323471 Disease Relevance 0.37 Pain Relevance 0
Human TAP1 protein was detected in splenocytes by immunoblotting (Figure 4A), and RT-PCR analysis showed that both human TAP1 and human TAP2 mRNA were present (Figure 4B).
Localization (present) of TAP1
2) Confidence 0.73 Published 2005 Journal PLoS Pathogens Section Body Doc Link PMC1323471 Disease Relevance 0.33 Pain Relevance 0
The mean HAM-D-17 and CGIS scores of these 15 patients decreased significantly at the end of 4 weeks on a higher dosage of fluoxetine (60 or 80 mg/day) with respect to the beginning of the four-week study.
Localization (decreased) of HAM-D-17 in D-17 associated with fluoxetine
3) Confidence 0.65 Published 1992 Journal J Affect Disord Section Abstract Doc Link 1430659 Disease Relevance 0.09 Pain Relevance 0.48
The results of long-term administration of leuprorelin acetate depot (TAP-144-SR), a sustained-release preparation of luteinising hormone-releasing hormone (LH-RH) agonist, to 40 stage D prostate cancer patients who had had no previous hormonal therapy, have been analyzed.
Localization (release) of TAP-144-SR associated with agonist and prostate cancer
4) Confidence 0.01 Published 1992 Journal Jpn. J. Clin. Oncol. Section Abstract Doc Link 1518166 Disease Relevance 0.17 Pain Relevance 0.09

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox